Neurocrine Biosciences Inc

Ownership Transactions Reported by 21 Insiders

Symbol
NBIX on Nasdaq
Location
6027 Edgewood Bend Court, San Diego, California

Insiders trading volume in the past year

Neurocrine Biosciences Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Kevin Charles Gorman Chief Executive Officer, Director $71.4M -$23.8M -25% Feb 13, 2024
Kyle Gano Chief Business Development Off $19.2M -$10.6M -35.7% Feb 13, 2024
Gary A. Lyons Director $18.1M -$6.03M -25% Aug 13, 2024
Darin Lippoldt Chief Legal Officer $10.4M -$7.23M -41% Aug 1, 2024
Eiry Roberts Chief Medical Officer $6.87M -$13.9M -67% Feb 13, 2024
Eric Benevich Chief Commercial Officer $6.48M -$23.8M -78.6% Apr 15, 2024
Malcolm Lloyd-Smith Chief Integration Officer $5.92M Feb 6, 2023
William H. Rastetter Director $5.91M -$3.54M -37.5% Aug 15, 2024
Matt Abernethy Chief Financial Officer $5.13M -$7.07M -57.9% Aug 13, 2024
Richard F. Pops Director $4.89M -$5.79M -54.2% May 22, 2024
Stephen Sherwin Director $3.94M -$5.34M -57.5% May 29, 2024
Julie Cooke Chief Human Resources Officer $3.54M -$7.27M -67.3% Aug 1, 2024
Jude Onyia Chief Scientific Officer $3.18M -$473K -13% Feb 13, 2024
Ingrid Delaet Chief Regulatory Officer $2.74M -$4.28M -60.9% Aug 13, 2024
David W. Boyer Chief Corp. Affairs Officer $1.47M -$943K -39% Feb 13, 2024
Morrow George J Director $1M -$5.58M -84.8% May 22, 2024
Johanna Mercier Director $718K May 22, 2024
Dimitri E. Grigoriadis Chief Research Officer $631K Jan 31, 2022
Shalini Sharp Director $564K -$157K -21.8% May 22, 2024
Leslie V. Norwalk Director $564K -$1.24M -68.8% May 22, 2024
Christine A. Poon Director $423K May 22, 2024

Recent Insider Transactions by Companies or Individuals for Neurocrine Biosciences Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.